WEERT, Netherlands and
KARLSRUHE, Germany, March 3, 2017 /PRNewswire/ -- Alcami, a
leading provider of custom development and manufacturing services
for the pharmaceutical and biotechnology industries, and Bruker
AXS, one of the world's leading suppliers of analytical X-ray
solutions, today announced the delivery of Bruker's D8 DISCOVER
HTS™ high-throughput X-ray Diffraction (XRD) analysis system
to the Alcami site in Weert, The
Netherlands.
As part of a collaboration agreement, Alcami will use the D8
DISCOVER HTS to add XRD capabilities to their laboratory service
portfolio and make it available as part of their
workflow-integrated solution. The D8 DISCOVER HTS combines advanced
sample analysis throughput capabilities with great flexibility.
This highly innovative system perfectly matches the application
requirements of the pharmaceutical industry for crystallization
studies, polymorph screening, structure solution, phase
identification and crystallite size determination under ambient and
non-ambient conditions. With its unparalleled high-throughput
screening capability, the D8 DISCOVER HTS provides opportunities
for optimization of the development and production of
pharmaceuticals.
"We are pleased to supply our latest high-throughput screening
solution, the D8 DISCOVER HTS, to Alcami," commented Dr.
Lutz Bruegemann, General Manager XRD
and Vice President of Bruker AXS. "High-throughput screening of
well plates using X-ray diffraction is a powerful and important
analysis technique for accelerating the development and improving
the quality of pharmaceutical products. Alcami is a competent
partner with excellent relations to many leading pharmaceutical
companies. We look forward to a fruitful collaboration."
"As we continue to further invest in our people, technology,
equipment and capabilities across all sites, we are pleased to
partner with Bruker in bringing this unique system to our Weert,
Netherlands, facility," stated
Ted Dolan, Alcami's Chief Operating
Officer. "The addition of the D8 DISCOVER HTS to our Center of
Excellence for Solid-State Chemistry in Weert will further enhance
our capabilities and expertise in this area, including our ProForm
Select™ integrated service offering for solid-state chemistry and
formulation development to help the pharma/biotech industry meet
important milestones and maintain stability in drug
development."
About D8 DISCOVER™
The D8 DISCOVERTM
is a unique multi-purpose X-ray diffractometer platform that can be
configured to meet customers' analytical requirements. Due to its
flexibility, the D8 DISCOVER provides top-class results in the
structure analysis of all kinds of materials from powders in the
pharmaceutical industry to crystalline structures in semiconductor
devices. Equipped with leading technology X-ray sources, sample
stages and detectors, the D8 DISCOVER maximizes the analytical
benefit in research, development and process control. Via
SmartCalibTM intelligence, the D8 DISCOVER can be
reconfigured without time consuming alignment, leaving more time
for data collection.
About Bruker Corporation (NASDAQ: BRKR)
For more than
50 years, Bruker has enabled scientists to make breakthrough
discoveries and develop new applications that improve the quality
of human life. Bruker's high-performance scientific research
instruments and high-value analytical and diagnostic solutions
enable customers to explore life and materials at molecular,
cellular and microscopic levels.
In close cooperation with our customers, Bruker is enabling
innovation, productivity and customer success in life science
molecular research, in applied and pharma applications, in
microscopy, nano-analysis and industrial applications, as well as
in cell biology, preclinical imaging, clinical research,
microbiology and molecular diagnostics. For more information,
visit www.bruker.com.
About Alcami
Alcami is a world-class supplier of
comprehensive pharmaceutical development and manufacturing
services. With seven sites across the globe, our combined
capabilities include API development and manufacturing, solid-state
chemistry, formulation development, analytical development and
testing services, clinical and commercial finished dosage form
manufacturing (oral solid dose and parenteral), packaging, and
stability services. For more information, visit
www.alcaminow.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/alcami-invests-in-brukers-d8-discover-hts-system-for-high-throughput-x-ray-diffraction-screening-in-pharmaceutical-formulation-development-300417677.html
SOURCE Alcami